Prognostic and Clinicopathological Value of Survivin in Diffuse Large B-cell Lymphoma: A Meta-Analysis

Up to date, survivin, a well-known inhibitor of apoptosis, has attracted considerable attention as a potential biomarker and therapeutic target in diffuse large B-cell lymphoma (DLBCL). Nevertheless, there still remains no consensus on heterogeneous results. Herein, a meta-analysis was performed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ya, Wang, Jianhong, Sui, Xiaohui, Li, Ying, Lu, Kang, Fang, Xiaosheng, Jiang, Yujie, Wang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616623/
https://www.ncbi.nlm.nih.gov/pubmed/26356696
http://dx.doi.org/10.1097/MD.0000000000001432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616623/
https://www.ncbi.nlm.nih.gov/pubmed/26356696
http://dx.doi.org/10.1097/MD.0000000000001432

Ejemplares similares